Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

MDM1 – Schizophrenia

The link between MDM1 and Schizophrenia is currently supported by genome-wide association evidence. A systematic review of 22 independent GWAS identified a locus at MDM1 meeting genome-wide significance in a schizophrenia cohort (PMID:31096178).

No monogenic inheritance pattern, segregating variants, or case-level reports have been described in schizophrenia. No functional studies have directly assessed MDM1 variants in schizophrenia-relevant models. As such, the clinical validity remains limited, and further replication, variant-level analysis, and experimental validation are required to clarify MDM1's role in schizophrenia risk.

References

  • Journal of psychiatric research • 2019 • Unravelling the genetic basis of schizophrenia and bipolar disorder with GWAS: A systematic review. PMID:31096178

Evidence Based Scoring (AI generated)

Gene–Disease Association

Limited

Genome-wide association of MDM1 locus in one independent schizophrenia GWAS cohort

Genetic Evidence

Limited

Single GWAS signal; no variant-level or segregation data

Functional Evidence

No evidence

No functional studies linking MDM1 to schizophrenia